AbbVie Non-GAAP EPS of $3.00 beats by $0.08, revenue of $14.46B beats by $180M
by
Contributor since / Followers
Contributor since / Followers
4 weeks ago
- AbbVie press release (NYSE:ABBV): Q3 Non-GAAP EPS of $3.00 beats by $0.08.
- Revenue of $14.46B (+3.8% Y/Y) beats by $180M.
- Delivers Third-Quarter Net Revenues of $14.460 Billion, an Increase of 3.8 Percent on a Reported Basis or 4.9 Percent on an Operational Basis
- Raises 2024 Adjusted Diluted EPS Guidance Range from $10.67 – $10.87 to $10.90 – $10.94 vs. $10.85 consensus, which Includes an Unfavorable Impact of $0.64 Per Share Related to Acquired IPR&D and Milestones Expense Incurred Year-To-Date Through the Third Quarter 2024